
mSIRK
CAS No. 593267-11-9
mSIRK( —— )
Catalog No. M37262 CAS No. 593267-11-9
mSIRK (G-Protein βγ Binding Peptide) is a cell-permeable activator of ERK 1/2 with an EC50 of 2.5-5 μM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 61 | Get Quote |
![]() ![]() |
5MG | 77 | Get Quote |
![]() ![]() |
10MG | 117 | Get Quote |
![]() ![]() |
25MG | 182 | Get Quote |
![]() ![]() |
50MG | 273 | Get Quote |
![]() ![]() |
100MG | 408 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamemSIRK
-
NoteResearch use only, not for human use.
-
Brief DescriptionmSIRK (G-Protein βγ Binding Peptide) is a cell-permeable activator of ERK 1/2 with an EC50 of 2.5-5 μM.
-
DescriptionmSIRK (G-Protein βγ Binding Peptide) is an cell-permeable activator of ERK1/2, with EC50 of 2.5-5 μM. mSIRK disrupts the interaction between α and βγ subunits and promotes α subunit dissociation without stimulating nucleotide exchange.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetERK
-
RecptorERK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number593267-11-9
-
Formula Weight1948.31
-
Molecular FormulaC93H150N20O25
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC([C@H](CC1=CC=C(O)C=C1)NC(CNC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CCCCCCCCCCCCC)=O)CO)=O)[C@H](CC)C)=O)CCCNC(=N)N)=O)CCCCN)=O)C)=O)CC(C)C)=O)CC(N)=O)=O)[C@H](CC)C)=O)CC(C)C)=O)=O)(=O)N2[C@H](C(N[C@H](C(N[C@@H](CC3=CC=C(O)C=C3)C(N[C@@H](CC(O)=O)C(O)=O)=O)=O)CC(O)=O)=O)CCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Farida Goubaeva, et al. Stimulation of Cellular Signaling and G Protein Subunit Dissociation by G Protein βγ Subunit-binding Peptides. J Biol Chem. 2003 May 30;278(22):19634-41.?
molnova catalog



related products
-
ERK-IN-4
ERK-IN-4 is a cell-permeable ERK inhibitor with potential antiproliferative effects for the study of diseases caused by immune dysfunction.
-
VX-11e
A potent, selective, and orally bioavailable inhibitor of ERK2 with Ki of <2 nM.
-
Ulixertinib hydrochl...
Ulixertinib hydrochloride (Ulixertinib HCl) is an orally available, selective and potent ERK1/2 inhibitor with anticancer and antitumor activity that inhibits the NB cell cycle and promotes apoptosis, and may be used in the study of solid tumors.